Since in the initial experiments VLX60 was found most active against a cell line from colon cancer we included colon cancer models able to associate the activity to the KRAS and BRAF mutation status, established to have predictive and/or prognostic importance in this tumor type [27, 28]. The gene discussed is BRAF; the disease is colonic neoplasm.